These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17874992)

  • 21. Net clinical benefit of warfarin: extending the reach of antithrombotic therapy for atrial fibrillation.
    Fuster V; Chinitz JS
    Circulation; 2012 May; 125(19):2285-7. PubMed ID: 22514253
    [No Abstract]   [Full Text] [Related]  

  • 22. [From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?].
    Colivicchi F
    Monaldi Arch Chest Dis; 2013 Jun; 80(2):55-6. PubMed ID: 24494406
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolution of stroke prevention in nonvalvular atrial fibrillation patients.
    Lee RJ
    J Am Coll Cardiol; 2014 Jul; 64(1):13-5. PubMed ID: 24998122
    [No Abstract]   [Full Text] [Related]  

  • 24. Dual antiplatelet therapy versus warfarin anticoagulation in patients undergoing catheter ablation of atrial fibrillation.
    Ling Z; Jia F; Xu Y; Su L; Liu Z; Du H; Yang X; Lan X; Xiao P; Chen W; Fan J; Luo S; Yin Y; Nazarian S
    Int J Cardiol; 2014 May; 173(2):345-6. PubMed ID: 24679686
    [No Abstract]   [Full Text] [Related]  

  • 25. Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation.
    Phan K; Wang N; Pison L; Kumar N; Hitos K; Thomas SP
    Int J Cardiol; 2015 Jun; 189():199-203. PubMed ID: 25897906
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
    Bedeir K; Giugliano RP; Ramlawi B
    Int J Cardiol; 2016 Nov; 222():615-619. PubMed ID: 27521536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?
    Waks JW; Manning WJ
    J Am Coll Cardiol; 2015 Jun; 65(24):2624-2627. PubMed ID: 26088301
    [No Abstract]   [Full Text] [Related]  

  • 28. Warfarin for stroke prevention in atrial fibrillation: time to switch?
    Ahmad Y; Lip GY
    Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
    [No Abstract]   [Full Text] [Related]  

  • 29. Age adjusted warfarin.
    Gallo JH
    Aust N Z J Med; 2000 Aug; 30(4):512. PubMed ID: 10985522
    [No Abstract]   [Full Text] [Related]  

  • 30. Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    Messori A; Trippoli S
    J Am Coll Cardiol; 2015 Nov; 66(18):2056-2058. PubMed ID: 26516013
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter regarding article by Hylek et al, "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation".
    Ono A; Kawamura I; Fujita T
    Circulation; 2007 Nov; 116(20):e538. PubMed ID: 17998467
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
    Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reply: Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    Holmes DR
    J Am Coll Cardiol; 2015 Nov; 66(18):2058. PubMed ID: 26516014
    [No Abstract]   [Full Text] [Related]  

  • 34. Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA?
    Stöllberger C; Finsterer J
    Lancet Neurol; 2012 Aug; 11(8):659; author reply 660-1. PubMed ID: 22814536
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of atrial fibrillation with warfarin in Rhode Island.
    Gifford DR; Silverman LR
    Med Health R I; 2000 May; 83(5):156-7. PubMed ID: 10874820
    [No Abstract]   [Full Text] [Related]  

  • 36. Atrial fibrillation and stroke prevention.
    Hart RG
    N Engl J Med; 2003 Sep; 349(11):1015-6. PubMed ID: 12968083
    [No Abstract]   [Full Text] [Related]  

  • 37. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
    Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique warfarin therapy in Japan.
    Mitamura H
    Circ J; 2011; 75(9):2048-9. PubMed ID: 21817809
    [No Abstract]   [Full Text] [Related]  

  • 39. When should I stop anticoagulation for atrial fibrillation?
    Greiver M
    CMAJ; 2005 May; 172(11):1437. PubMed ID: 15911854
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of oral anticoagulation in management of atrial fibrillation.
    Crystal E; Connolly SJ
    Heart; 2004 Jul; 90(7):813-7. PubMed ID: 15201261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.